Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.

James Altucher is an AI expert and one of America's most trusted technology forecasters. Known for his early predictions like for the success of Facebook in 2007 and, Altucher has shown a track record ...

Journey Medical's future hinges on Emrosi, a new formulation of minocycline for rosacea, showing superior efficacy. Read why ...

Davos 2025 - giving AI responsibility to CDOs results in great AI no-one uses, says Sanofi CEO Paul Hudson [People] delegate AI to CDOs, and it's the biggest mistake you can make.

Filament Health Corp.  (Cboe CA: FH) ("Filament" or the "Company"), a clinical?stage natural psychedelic drug development company, today announced that it has shipped its botanical psilocybin drug ...

CD Bioparticles announces its comprehensive portfolio of products for the isolation and extraction of Exosome DNA & RNA. NEW YORK, NY, UNITED ...

Detailed price information for Ocular Therapeut (OCUL-Q) from The Globe and Mail including charting and trades.

Raritan: Johnson & Johnson has announced it has initiated the submission of an original New Drug Application with the U.S. Food and ... 2024 Congress as a late-breaking oral presentation showed an ...

Detailed price information for Perspective Therapeutics Inc (CATX-A) from The Globe and Mail including charting and trades.

Protecting skin from photoaging and photocarcinogenesis requires not only sunscreen but also use of topical antioxidants, ...

"The government cannot be a welfare program for everybody doing low quality, low credibility, irreproducible, low value of ...

The Global Hyper Automation Market Size is projected to grow at a CAGR of 18.25% from 2024 to 2031, according to a new report published by Verified Market Research®. The report reveals that the market ...